Results 201 to 210 of about 577,742 (361)

Diffuse cranial nerve infiltration in acute lymphoblastic leukemia: MRI diagnosis. [PDF]

Radiol Case Rep
Ali M, Zineb M, Ayoub C, Jalal EK, Oula A, El Mahdi C, Asmae OA, Siham AR.   +7 more
europepmc   +1 more source

Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis

, 1980
G A Omura, Samuel J. Moffitt, WR Vogler, MM Salter   +3 more
openalex   +1 more source

Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients. [PDF]

, 1987
Fatih M. Uckun, John H. Kersey, K Gajl-Peczalska, Nyla A. Heerema, Arthur J. Provisor, D. Haag, Gerald Gilchrist, C. W. Song, D Arthur, James S. Roloff   +9 more
openalex   +1 more source

NEAT1 lncRNA overexpression results in short‐term progression and poor treatment outcome in childhood B‐ALL

British Journal of Haematology, EarlyView.
Childhood acute lymphoblastic leukaemia (chALL) remains the most prevalent malignancy in children and adolescents. Improving risk stratification and providing personalized prognosis and treatment remain major clinical challenges. NEAT1 lncRNA overexpression constitutes a powerful, independent predictor of poor treatment outcomes and disease progression
Marieta Xagorari, Antonios Marmarinos, Dimitrios Doganis, Maria Nikita, Evgenia Magkou, Angeliki‐Eleni Sfetsiori, Margarita Baka, Lydia Kossiva, Sofia Pasparaki, Alexandra Soldatou, Maria Tsolia, Andreas Scorilas, Dimitrios Gourgiotis, Margaritis Avgeris   +13 more
wiley   +1 more source

Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens Cancer Study Group [PDF]

, 1981
S. Leikin, Donald R. Miller, H Sather, Vincent Albo, E Esber, A Johnson, N Rogentine, D Hammond   +7 more
openalex   +1 more source

A characteristic gene expression profile regulated by ACIN1::NUTM1 fusion in a newly identified infant leukaemic cell line and an ACIN1::NUTM1‐inducible model

British Journal of Haematology, EarlyView.
An ACIN1::NUTM1‐positive ALL cell line, KOPN32, which was previously established from a relapsed infant‐ALL case, was newly identified. Comparison using 94 BCP‐ALL cell lines, an ACIN1::NUTM1‐inducible ALL model and clinical sample data revealed upregulation of HOXA9, HOXA10, SKIDA1 and BMI1, indicating direct involvement of ACIN1::NUTM1 fusion in the ...
Minori Tamai, Chiaki Komatsu, Keiko Kagami, Shin Kasai, Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Chihiro Tomoyasu, Toshihiko Imamura, Satoshi Oguri, Sumio Iwasaki, Takanori Teshima, Yasushi Yatabe, Takeshi Inukai   +13 more
wiley   +1 more source

Blinatumomab in pediatric B-acute lymphoblastic leukemia. [PDF]

Front Immunol
Cheng Y, Liu A.
europepmc   +1 more source

Italian registry of patients off therapy after childhood acute lymphoblastic leukemia. Results after first phase of data collection [PDF]

, 1986
Maria Grazia Zurlo, Guido Pastore, Giuseppe Masera, Benedetto Terracin, Roberto G. Burgio, Adriana Ceci, G Digilio, Carlo Guazzelli, Riccardo Haupt, Margherita Lo Curto, Enrico Madon, Franco Mandelli, G Paolucci, Luigi Zanesco   +13 more
openalex   +1 more source

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

New England Journal of Medicine, 2014
K. Roberts, Yongjin Li, D. Payne-Turner, R. Harvey, Yung‐Li Yang, Deqing Pei, K. McCastlain, L. Ding, Charles Lu, Guangchun Song, Jing Ma, J. Becksfort, Michael C. Rusch, Shann-Ching Chen, J. Easton, Jinjun Cheng, Kristy Boggs, Natalia Santiago-Morales, I. Iacobucci, R. Fulton, Ji-Rong Wen, M. Valentine, Cheng Cheng, S. Paugh, M. Devidas, I. Chen, S. Reshmi, Amy A. Smith, Erin K. Hedlund, P. Gupta, Panduka Nagahawatte, Gang Wu, Xiang Chen, D. Yergeau, Bhavin Vadodaria, H. Mulder, N. Winick, E. Larsen, W. Carroll, N. Heerema, A. Carroll, G. Grayson, S. Tasian, A. Moore, F. Keller, Melissa J. Frei-Jones, J. Whitlock, E. Raetz, D. White, T. Hughes, Jaime M Guidry Auvil, Malcolm A. Smith, G. Marcucci, C. Bloomfield, K. Mrózek, J. Kohlschmidt, W. Stock, S. Kornblau, M. Konopleva, E. Paietta, C. Pui, S. Jeha, M. Relling, W. Evans, D. Gerhard, J. Gastier-Foster, E. Mardis, R. Wilson, M. Loh, J. Downing, S. Hunger, C. Willman, Jinghui Zhang, C. Mullighan   +73 more
semanticscholar   +1 more source

Early prediction of subsequent peg‐asparaginase inactivation in acute lymphoblastic leukaemia patients—A NOPHO ALL2008 study

British Journal of Haematology, EarlyView.
Summary Polyethylene glycol (peg)‐asparaginase plays a crucial role in acute lymphoblastic leukaemia (ALL) treatment, yet its associated toxicity often leads to treatment discontinuation, elevating relapse risk. Hypersensitivity with inactivation of asparaginase is common and often associated with severe allergic reactions.
Merete Dam, Maddalena Centanni, Daniel Centanni, Lena E. Friberg, Mats O. Karlsson, Line S. Lynggaard, Inga M. Johannsdottir, Kristi Lepik, Goda E. Vaitkeviciene, Laimonas Griskevicius, Tuuli Pöyhönen, Marja Pyörälä, Ólafur G. Jónsson, Petter Quist‐Paulsen, Kjeld Schmiegelow, Tania Christoforaki, Ulrik Overgaard, Stefan N. Hansen, Birgitte K. Albertsen   +18 more
wiley   +1 more source